Andrew D. Spruiell advises established and emerging companies in corporate, licensing, commercial, and acquisitive transactions. Andrew’s matters have involved buy- and sell-side acquisitions, initial formation, venture capital and private equity financings, mergers and acquisitions, strategic business partnerships and collaborations as well as complex intellectual property licensing.
Andrew works with clients in a variety of industries, but focuses on life sciences, technology, and manufacturing. He is a member of Ballard Spahr’s Life Science Group, Fintech and Payments Team, and Emerging Companies and Venture Capital Group.
- Represented Japanese food and supplements company in negotiating, structuring and documenting collaboration, research and development agreements with a U.S. microbiome testing and technology company, under which our client developed new products, services and marketing channels on a global scale
- Represented urban farming company in strategic partnership with several of the largest U.S. food distribution companies in connection with establishing urban farming cultivation campuses
- Represented software company in negotiating, structuring and documenting a collaborative research and development agreement with a large medical technology company to develop medical imaging software
Colorado Bar Association
American Bar Association
Board Memberships & Community Service
Denver Children’s Home, Board Member and Secretary 2017-2020
University of Chicago Law School (J.D. 2012)University of Oklahoma (B.A. 2007, summa cum laude)
Phi Beta Kappa